GTC
Ghost Tree Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $8.66M | Buy |
450,000
+100,000
| +29% | +$1.93M | 2.62% | 11 |
|
2024
Q2 | $7.19M | Buy |
350,000
+200,000
| +133% | +$4.11M | 2.25% | 15 |
|
2024
Q1 | $3.57M | Buy |
+150,000
| New | +$3.57M | 0.99% | 29 |
|
2023
Q4 | – | Sell |
-200,000
| Closed | -$2.9M | – | 61 |
|
2023
Q3 | $2.9M | Sell |
200,000
-150,000
| -43% | -$2.18M | 0.96% | 25 |
|
2023
Q2 | $7.33M | Buy |
350,000
+25,000
| +8% | +$523K | 2.42% | 14 |
|
2023
Q1 | $6.86M | Buy |
325,000
+175,000
| +117% | +$3.7M | 2.03% | 17 |
|
2022
Q4 | $3.82M | Sell |
150,000
-50,000
| -25% | -$1.27M | 1.63% | 23 |
|
2022
Q3 | $4.81M | Sell |
200,000
-25,000
| -11% | -$601K | 1.35% | 19 |
|
2022
Q2 | $4.33M | Hold |
225,000
| – | – | 2.25% | 18 |
|
2022
Q1 | $3.91M | Sell |
225,000
-75,000
| -25% | -$1.3M | 0.85% | 19 |
|
2021
Q4 | $6.57M | Sell |
300,000
-275,000
| -48% | -$6.02M | 2.35% | 13 |
|
2021
Q3 | $11M | Sell |
575,000
-300,000
| -34% | -$5.73M | 3.21% | 8 |
|
2021
Q2 | $15M | Sell |
875,000
-300,000
| -26% | -$5.15M | 4.13% | 6 |
|
2021
Q1 | $26.3M | Sell |
1,175,000
-175,000
| -13% | -$3.91M | 6.18% | 1 |
|
2020
Q4 | $30M | Buy |
1,350,000
+925,000
| +218% | +$20.6M | 6.69% | 1 |
|
2020
Q3 | $6.27M | Buy |
425,000
+240,000
| +130% | +$3.54M | 1.81% | 18 |
|
2020
Q2 | $2.74M | Sell |
185,000
-65,000
| -26% | -$963K | 0.72% | 32 |
|
2020
Q1 | $2.74M | Buy |
+250,000
| New | +$2.74M | 0.73% | 26 |
|
2017
Q3 | – | Sell |
-200,000
| Closed | -$2.79M | – | 60 |
|
2017
Q2 | $2.79M | Buy |
+200,000
| New | +$2.79M | 0.58% | 45 |
|